Altmetric

2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with treatment recommendations summary

File Description SizeFormat 
1-s2.0-S0300957218310013-main.pdfPublished version653.75 kBAdobe PDFView/Open
ILCOR CoSTR Summary PDF Word FINAL DRAFT for PADDY WHITE.docxAccepted version265.03 kBMicrosoft WordView/Open
Title: 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with treatment recommendations summary
Authors: Soar, J
Donnino, MW
Maconochie, I
Aickin, R
Atkins, DL
Andersen, LW
Berg, KM
Bingham, R
Böttiger, BW
Callaway, CW
Couper, K
Couto, TB
De Caen, AR
Deakin, CD
Drennan, IR
Guerguerian, A-M
Lavonas, EJ
Meaney, PA
Nadkarni, VM
Neumar, RW
Ng, K-C
Nicholson, TC
Nuthall, GA
Ohshimo, S
O'Neil, BJ
Ong, GY-K
Paiva, EF
Parr, MJ
Reis, AG
Reynolds, JC
Ristagno, G
Sandroni, C
Schexnayder, SM
Scholefield, BR
Shimizu, N
Tijssen, JA
Van de Voorde, P
Wang, T-L
Welsford, M
Hazinski, MF
Nolan, JP
Morley, PT
ILCOR Collaborators
Item Type: Journal Article
Abstract: The International Liaison Committee on Resuscitation has initiated a continuous review of new, peer-reviewed, published cardiopulmonary resuscitation science. This is the second annual summary of International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations that includes the most recent cardiopulmonary resuscitation science reviewed by the International Liaison Committee on Resuscitation. This summary addresses the role of antiarrhythmic drugs in adults and children and includes the Advanced Life Support Task Force and Pediatric Task Force consensus statements, which summarize the most recent published evidence and an assessment of the quality of the evidence based on Grading of Recommendations, Assessment, Development, and Evaluation criteria. The statements include consensus treatment recommendations approved by members of the relevant task forces. Insights into the deliberations of each task force are provided in the Values and Preferences and Task Force Insights sections. Finally, the task force members have listed the top knowledge gaps for further research.
Issue Date: 4-Dec-2018
Date of Acceptance: 1-Nov-2018
URI: http://hdl.handle.net/10044/1/66633
DOI: https://dx.doi.org/10.1161/CIR.0000000000000611
ISSN: 0009-7322
Publisher: American Heart Association
Start Page: e714
End Page: e730
Journal / Book Title: Circulation
Volume: 138
Issue: 23
Copyright Statement: © 2018 by the American Heart Association, Inc., and the European Resuscitation Council. This is a non-final version of an article published in final form in Circulation, Vol 138, No.23: e714–e730, https://dx.doi.org/10.1161/CIR.0000000000000611
Keywords: AHA Scientific Statements
adolescent
anti-arrhythmia agents
cardiac arrest
cardiopulmonary resuscitation
child
infant
ventricular fibrillation
ILCOR Collaborators
1103 Clinical Sciences
1102 Cardiovascular Medicine And Haematology
1117 Public Health And Health Services
Cardiovascular System & Hematology
Publication Status: Published
Conference Place: United States
Online Publication Date: 2018-11-05
Appears in Collections:Department of Medicine
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx